// App-Quantinova.ai

3122 : A strategy for detecting high-risk groups for pancreatic cancer with glycol-biomarkers

Researchers

Presenter

  • Eiji Miyoshi

Principal Investigators

  • Tomohiro Maekawa

  • Makiko Ueda

  • Mayuka Shimomura

  • Shinji Takamatsu

  • Kotarosumitomo Nakayama

  • Yoshihiro Kamada

  • Yasuhiko Tomita

Medical Centers

  • Osaka University Graduate School of Medicine, Suita, Japan

  • Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Liver cancer

  • Hereditary pancreatitis

  • Pancreatic cancer

  • Pancreatitis

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Carbohydrate antigen 19-9

  • Fucosylated haptoglobin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved